Business
-
Lightlake Therapeutics, which is developing intranasal naloxone to treat eating disorders, has announced the appointment of board member Kevin Pollack as Chief Financial Officer. Pollack joined the board of directors in April 2012. Lightlake Chief… Read more . . .
-
Inhalation and particle engineering specialist Hovione and Swiss chemical development company Solvias have announced an agreement to collaborate on development and manufacturing of co-crystallized drugs. According to Hovione, “This strengthens Hovione’s expertise and experience in… Read more . . .
-
The FDA issued a letter to Alcon dated November 13, 2012 regarding a sales aid that the agency says overstates the efficacy of Alcon’s Patanase olopatadine hydrochloride nasal spray. In the four-page letter, the agency… Read more . . .
-
Fortical salmon calcitonin nasal spray manufacturer Unigene says that it is in danger of running out of cash before the end of the first quarter of 2013, due in part to the EMA’s July 2012… Read more . . .
-
Vienna, Austria-based Marinomed has announced the granting of Chinese patent No. CN101678040, titled “Antiviral Polymer,” for a component of its Mavirex technology platform. According to the company, the patent covers prevention and treatment of the… Read more . . .
-
OptiNose has announced Phase 3 results from a study of its sumatriptan nasal powder for the treatment of migraine, as well as a grant from the Research Council of Norway to study nasal delivery of… Read more . . .
-
Pearl Therapeutics has raised $65 million from current investors to enable initiation of Phase 3 trials for its PT003 glycopyrrolate (GP)/formoterol fumarate (FF) MDI for the treatment of COPD, the company says. This round of… Read more . . .
-
Boehringer Ingelheim has announced an €85 million expansion to the BI microParts GmbH inhaler manufacturing facililty in Dortmund, Germany meant to double its annual production of Respimat inhalers to 44 million by 2015. Filling of… Read more . . .
-
Two companies that provide services to OINDP developers and manufacturers have been awarded major prizes recently. The 2012 British Engineering Excellence Awards recognized device design experts Team Consulting as “Consultancy of the Year.” Criteria for… Read more . . .
-
According to the Associated Press, GlaxoSmithKline is extending its “Complete the Cycle” inhaler recycling program to 31 US cities, which were chosen because they account for about a third of all inhaler sales in the… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland